A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

When Mayor Linda Gorton testified against the East Kentucky Solar Energy proposal her testimony was not against the idea of ...

Threats of widespread tariffs and concerns about retaliation continue to stoke uneasiness in agriculture. With a growing ...

This story contains graphic details from proceedings in the trial of Anthony Patterson that involve alleged sex crimes ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...

When: Pequea Valley school board meeting, Nov. 14. What happened: The board approved final furniture and cleaning purchases ...

Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...

Ann Arbor-based companies dominate our ranking of Michigan's largest venture capital firms Magic mushrooms? Two Marquette ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

The second phase of Thailand's "digital wallet" handout scheme will be launched in January and distribute 40 billion baht ($1 ...

NEWARK, CA / ACCESSWIRE / November 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that the company will host a conference call and webcast to announce its ...

Talks with the FDA haven’t gone according to plan. Seeking a streamlined pathway, Neurogene submitted a Regenerative Medicine ...